Parkinson's disease trials recruiting in District of Columbia

All Parkinson's disease trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
  NCT06285643 · Phase: Phase 2 · Ages: 45 Years to 75 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
  NCT07174310 · Phase: Phase 3 · Ages: 50 Years to 85 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
  NCT06944522 · Phase: Phase 3 · Ages: 45 Years to 75 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Social & QoL Behaviors in Parkinson's Disease
  NCT06385184 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.